A 30-minute public webinar will be held on June 9, 2022 at 09:00 AM EDT with representatives from CARB-X, BARDA, Wellcome and NIAID to discuss the global health issues of AMR, and how CARB-X and its partners are working together to address them. The webinar celebrates a recent announcement in which BARDA and Wellcome have committed up to an additional […]
Vaccination programs are known to be effective to both promote the prudent use of antibiotics and to prevent the spread of AMR. JPIAMR, in partnership with the Medical Research Council and BactiVac Network, are holding a live webinar to identify opportunities and priorities for vaccine research from an immunological perspective to a wider translational context, in the field […]
The prosperity of the modern world is threatened by the emergence of drug resistant pathogens, pesticide-resistant insects and herbicide-resistant weeds. Novel investigational cancer drugs increase life expectancy, but fail when resistance develops. The same principles of evolution drive the development of resistance in all of these contexts, yet each field attacks the problem of resistance […]
The prosperity of the modern world is threatened by the emergence of drug resistant pathogens, pesticide-resistant insects and herbicide-resistant weeds. Novel investigational cancer drugs increase life expectancy, but fail when resistance develops. The same principles of evolution drive the development of resistance in all of these contexts, yet each field attacks the problem of resistance […]
On 26 July, James J. Collins and Richard Lee will be discussing the use of Synthetic biology and interdisciplinary approaches for antibiotic discovery.
In this webinar, the speakers will discuss will provide an overview of basic animal models and explain the basis for their selection and limitations for specific situations and needs to study the activity of antibiotics. The speakers will give the following presentations: - Overview of common animal models (Lynn Miesel) - Zebrafish larvae as an […]
On 23 August, Michael N. Dudley and Glenn Dale will discuss the Challenges and options in developing antibiotic combinations.
Since 2015, the World Antimicrobial Resistance Congress has attracted top thought leaders, hospitals, companies, and policymakers as the annual, go-to event in the Antimicrobial Resistance (AMR) space. We have grown into the most impactful event in advancing solutions to combat this pressing global health crisis. Diagnostic developers, antibiotic biotechs & pharmaceutical companies, stewardship technologies, access […]
The EMBO Workshop on Tuberculosis 2022, originally planned for September 2020 and postponed to 2022 due to the Covid-19 pandemic, has recently received again the support from EMBO, and is now scheduled to be held from September 12-16, 2022 at the Conference Centre (CIS) of the Institut Pasteur in Paris. The EMBO Workshop on Tuberculosis 2022 will be […]
Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements […]
